Stanko has for more than 35 years worked across academia, health care, pharmaceutical industry, private venture and regulatory authorities and has accrued a broad value chain experience both as contributor and as leader across multiple diseases/therapeutic areas.
He has most recently been Vice President of Medical & Science (Cardiovascular, Kidney and Alzheimer Disease area) in Novo Nordisk A/S and is now working as an independent senior life science advisor and innovation architect.
I’m excited to work with HeartBeat.bio as the team and its unique state-of-the-art Cardiod platform has the potential to unlock new opportunities for cardiovascular drug discovery and therapeutic innovation.
Site by
